SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-025673
Filing Date
2017-04-05
Accepted
2017-04-05 16:37:52
Documents
1
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4478
  Complete submission text file 0001209191-17-025673.txt   5884
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 200 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hagen Brett R (Reporting) CIK: 0001681782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37695 | Film No.: 17743025